Shortly after we published Sarah Vogel’s post urging the FDA to finally make a decision about the safety of bisphenol A, the agency did just that. In a conference call with reporters yesterday, FDA deputy commissioner Joshua Sharfstein stated that the agency has concerns about health risks associated with the widely used chemical and is conducting studies to help determine whether regulatory action is necessary. The Washington Post’s Lyndsey Layton has the full story.